Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Apr 14, 2017 · 10-Q · 45 days after period end · 0001640334-17-000697
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$13.01K | -$5.09K | -$6.15K | -$6.60K |
| EPS Diluted | $0.00 | $0.00 | $0.00 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Feb 28, 2017 · filed Apr 14, 2017 · 45 d after period end
